Sarıcaoğlu, E. M. And Yoruk, F. 2024. Antimicrobial Susceptibility of Various MRSA Clinical Isolates and the Impact of Glycopeptide MICs on Clinical and Microbiological Outcomes. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , no.2 , 102-111.

Sarıcaoğlu, E. M., & Yoruk, F., (2024). Antimicrobial Susceptibility of Various MRSA Clinical Isolates and the Impact of Glycopeptide MICs on Clinical and Microbiological Outcomes. INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , no.2, 102-111.

Sarıcaoğlu, ELİF, And FÜGEN YÖRÜK. "Antimicrobial Susceptibility of Various MRSA Clinical Isolates and the Impact of Glycopeptide MICs on Clinical and Microbiological Outcomes," INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , no.2, 102-111, 2024

Sarıcaoğlu, ELİF M. And Yoruk, FÜGEN. "Antimicrobial Susceptibility of Various MRSA Clinical Isolates and the Impact of Glycopeptide MICs on Clinical and Microbiological Outcomes." INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , no.2, pp.102-111, 2024

Sarıcaoğlu, E. M. And Yoruk, F. (2024) . "Antimicrobial Susceptibility of Various MRSA Clinical Isolates and the Impact of Glycopeptide MICs on Clinical and Microbiological Outcomes." INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY , no.2, pp.102-111.

@article{article, author={ELİF MUKİME SARICAOĞLU And author={FÜGEN YÖRÜK}, title={Antimicrobial Susceptibility of Various MRSA Clinical Isolates and the Impact of Glycopeptide MICs on Clinical and Microbiological Outcomes}, journal={INFECTIOUS DISEASES AND CLINICAL MICROBIOLOGY}, year=2024, pages={102-111} }